Matches in Wikidata for { <http://www.wikidata.org/entity/Q43955289> ?p ?o ?g. }
- Q43955289 description "2013 nî lūn-bûn" @default.
- Q43955289 description "2013年の論文" @default.
- Q43955289 description "2013年学术文章" @default.
- Q43955289 description "2013年学术文章" @default.
- Q43955289 description "2013年学术文章" @default.
- Q43955289 description "2013年学术文章" @default.
- Q43955289 description "2013年学术文章" @default.
- Q43955289 description "2013年學術文章" @default.
- Q43955289 description "2013年學術文章" @default.
- Q43955289 description "2013年學術文章" @default.
- Q43955289 description "2013年學術文章" @default.
- Q43955289 description "2013年學術文章" @default.
- Q43955289 description "2013年學術文章" @default.
- Q43955289 description "2013년 논문" @default.
- Q43955289 description "article científic" @default.
- Q43955289 description "article scientific" @default.
- Q43955289 description "article scientifique (publié 2013)" @default.
- Q43955289 description "articol științific" @default.
- Q43955289 description "articolo scientifico" @default.
- Q43955289 description "artigo científico (publicado na 2013)" @default.
- Q43955289 description "artigo científico (publicado na 2013)" @default.
- Q43955289 description "artigo científico" @default.
- Q43955289 description "artikull shkencor" @default.
- Q43955289 description "artikulong pang-agham" @default.
- Q43955289 description "artykuł naukowy" @default.
- Q43955289 description "artículo científico publicado en 2013" @default.
- Q43955289 description "artículu científicu espublizáu en 2013" @default.
- Q43955289 description "bilimsel makale" @default.
- Q43955289 description "bài báo khoa học" @default.
- Q43955289 description "mokslinis straipsnis" @default.
- Q43955289 description "naučni članak" @default.
- Q43955289 description "scienca artikolo" @default.
- Q43955289 description "scientific article" @default.
- Q43955289 description "teaduslik artikkel" @default.
- Q43955289 description "tieteellinen artikkeli" @default.
- Q43955289 description "tudományos cikk" @default.
- Q43955289 description "vedecký článok" @default.
- Q43955289 description "vetenskaplig artikel" @default.
- Q43955289 description "videnskabelig artikel (udgivet 2013)" @default.
- Q43955289 description "vitenskapelig artikkel" @default.
- Q43955289 description "vitskapeleg artikkel" @default.
- Q43955289 description "vědecký článek" @default.
- Q43955289 description "wetenschappelijk artikel" @default.
- Q43955289 description "wissenschaftlicher Artikel" @default.
- Q43955289 description "επιστημονικό άρθρο" @default.
- Q43955289 description "мақолаи илмӣ" @default.
- Q43955289 description "мақолаи илмӣ" @default.
- Q43955289 description "наукова стаття, опублікована в жовтні 2013" @default.
- Q43955289 description "научна статия" @default.
- Q43955289 description "научная статья" @default.
- Q43955289 description "научни чланак" @default.
- Q43955289 description "научни чланак" @default.
- Q43955289 description "գիտական հոդված" @default.
- Q43955289 description "מאמר מדעי" @default.
- Q43955289 description "سائنسی مضمون" @default.
- Q43955289 description "مقالة علمية" @default.
- Q43955289 description "مقالهٔ علمی" @default.
- Q43955289 description "২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q43955289 description "บทความทางวิทยาศาสตร์" @default.
- Q43955289 description "სამეცნიერო სტატია" @default.
- Q43955289 name "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 name "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 type Item @default.
- Q43955289 label "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 label "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 prefLabel "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 prefLabel "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 P1433 Q43955289-32526542-59A8-4001-9DA8-5F6A0C6B663D @default.
- Q43955289 P1476 Q43955289-4B9B4F45-3B31-4C4B-B64D-1C0CF53C248D @default.
- Q43955289 P2093 Q43955289-01957AEB-D779-415C-9502-8E59DCBEB2A2 @default.
- Q43955289 P2093 Q43955289-1CBD4D19-122F-4BE2-8E88-DF9C14B1EBF4 @default.
- Q43955289 P2093 Q43955289-2CAFC047-8E0E-4C5E-97E8-8674C2BC00AE @default.
- Q43955289 P2093 Q43955289-41E6337A-4776-400E-BC82-DACC14D0A779 @default.
- Q43955289 P2093 Q43955289-6FB06DF1-09C0-4D70-819A-52D246635D66 @default.
- Q43955289 P2093 Q43955289-88212E9D-FC05-4B1E-9A5B-845B600F560D @default.
- Q43955289 P2093 Q43955289-A3CD8D14-AFE8-4741-845E-ED2A0C4ECA7A @default.
- Q43955289 P2093 Q43955289-C58A2157-FB71-46C0-B4D8-25F4F0BED377 @default.
- Q43955289 P2093 Q43955289-F056F402-D295-4008-82E9-75BADC8333CC @default.
- Q43955289 P304 Q43955289-20CC4967-B431-41ED-AFA7-59F4D5772C40 @default.
- Q43955289 P31 Q43955289-4D4D3E7C-D7F3-4E0E-BF9D-0F3F56C52473 @default.
- Q43955289 P356 Q43955289-7A5E9A34-E58D-4A90-928B-03D1BB40B2E3 @default.
- Q43955289 P407 Q43955289-942E47CA-5605-4EEE-8F72-06237837C5D8 @default.
- Q43955289 P433 Q43955289-86E4036C-7E0D-430B-9869-27867847A413 @default.
- Q43955289 P478 Q43955289-08A0F48F-CEE8-46B7-A544-A69B364C49B1 @default.
- Q43955289 P50 Q43955289-032AD4FC-312E-4121-9F8B-7054BC440A72 @default.
- Q43955289 P577 Q43955289-9A30D23C-23F4-47EB-B942-8C7F552F822D @default.
- Q43955289 P698 Q43955289-7FF72336-C01A-4DB6-BC36-B72821949220 @default.
- Q43955289 P921 Q43955289-685F7791-2858-42C7-AE90-5756A9E80992 @default.
- Q43955289 P921 Q43955289-A366DE89-3977-4AC5-B321-4625C6D8F2A4 @default.
- Q43955289 P356 J.LUNGCAN.2013.09.014 @default.
- Q43955289 P698 24148258 @default.
- Q43955289 P1433 Q641464 @default.
- Q43955289 P1476 "A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer" @default.
- Q43955289 P2093 "Dietrich Hadler" @default.
- Q43955289 P2093 "Ewa Chmielowska" @default.
- Q43955289 P2093 "Joachim von Pawel" @default.
- Q43955289 P2093 "Jon Greenberg" @default.
- Q43955289 P2093 "Martin Reck" @default.
- Q43955289 P2093 "Martin Sebastian" @default.
- Q43955289 P2093 "Qiang Wang" @default.